Indomethacin vs ibuprofen: comparison of efficacy in the setting of conservative therapeutic approach

European Journal of Pediatrics

Volumn 174, Issue 5, 2015, Pages 615-620

  Malikiwi, Andra ^a   Roufaeil, Charlene ^a   Tan, Kenneth ^a   Sehgal, Arvind ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Efficacy; Ibuprofen; Indomethacin; Patent ductus arteriosus

Indexed keywords

CREATININE; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

BIRTH WEIGHT; BLOOD; COMPARATIVE STUDY; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMAN; MALE; NEWBORN; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIRTH WEIGHT; CREATININE; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; MALE; TREATMENT OUTCOME;

EID: 84940000638     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-014-2441-0     Document Type: Article

References (35)

1. Bancalari E, Calure N, Ganzalez A (2005) Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 88:192–201
2. Bose CL, Laughon M (2006) Treatment to prevent patency of the ductus arteriosus: beneficial or harmful? J Pediatr 148:713–714
3. Bose CL, Laughon MM (2007) Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 92:F498–F502
4. Coombs RC, Morgan MEI, Durbin GM, Booth IW, McNeish AS (1990) Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and indomethacin. Arch Dis Child 65:1067–1071
5. Desandes R, Jellimann JM, Rouabah M, Haddad F, Desandes E, Boubred F, Semama D, Vieux R, Hascoet JM (2012) Echocardiography as a guide for patent ductus arteriosus ibuprofen treatment and efficacy prediction. Pediatr Crit Care Med 13:324–327
6. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE (1976) Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 295:526–529
7. Glenen L, Kirkby S, Turenne W, Dysart K, Philadelphia PA (2009) Is indomethacin or ibuprofen more beneficial for treatment of patent ductus arteriosus? Pediatric Academic Societies Annual Meeting, Baltimore; E-PAS2009:510
8. Gournay V, Savagner C, Thiriez G, Kuster A, Roze JC (2002) Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 359:1486–1488
9. Heymann MA, Rudolph AM, Silverman NH (1976) Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 295:530–533
10. Hirt D, Van OB, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S (2008) An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamics study. Br J Clin Pharmacol 65:629–636
11. Insoft RM, Filkins BA (2009) Comparison of ibuprofen lysine versus indomethacin for the closure of patent ductus arteriosus: the results of a BWH NICU QI Project. Pediatric Academic Societies Annual Meeting, Baltimore; E-PAS2009:430
12. Keller RL, Clyman RI (2003) Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus. Pediatrics 112:583–587
13. Kluckow M, Jeffery M, Gill A, Evans N (2014) A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 99:F99–F104
14. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117:1113–1121
15. Konig K, Collins C, Casalaz D, Watkins A (2008) Efficacy of a second course of indomethacin for treatment of patent ductus arteriosus in preterm infants. 12th Annual Congress of Perinatal Society of Australia and New Zealand, Queensland; abstract A40
16. Kuniyoshi KM, Brock RS, Gebrekristos BH, Abad-Santos M, Hoang D, Modanlou HD, Willis BC, Beharry KD (2010) Effects of combined hyperoxia and cyclooxygenase inhibition in neonatal rat lungs. Am J Transl Res 2:332–344
17. Kushnir A, Pinheiro JM (2011) Comparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohorts. BMC Clin Pharmacol 11:8
18. McNamara PJ, Sehgal A (2007) Towards rational management of patent ductus arteriosus—the need for disease staging. Arch Dis Child 92:F424–F427
19. Moore GP, Lawrence SL, Maharajh G, Sumner A, Gaboury I, Barrowman N, Lemyreet B (2012) Therapeutic strategies, including a high surgical ligation rate, for patent ductus arteriosus closure in extremely premature infants in a North American centre. Paediatr Child Health 17:e26–e31
20. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, Sekar K et al (2009) Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123:e138–e144
21. Ohlsson A, Walia R, Shah SS (2008) Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews, Issue 1. Art. no.: CD003481
22. Ohlsson A, Walia R, Shah SS (2010) Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD003481
23. Pezzati M, Vangi V, Biagotti R, Bertini G, Cianciulli D, Rubaltelli FF (1999) Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135:733–738
24. Richards J, Johnson A, Fox G, Campbell M (2009) A second course of ibuprofen is effective in the closure of a clinically significant PDA in ELBW infants. Pediatrics 124:e287–e293
25. Sanju Y, Sheetal A, Arti M, Ajay D, Dubey NK, Puneet A, Dinesh KY (2014) Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial. Pediatr Cardiol 35:824–830
26. Santhanam S, Walker K, Shingde V, Bishuevel C, Halliday R, Badawi N (2008) Patent ductus arteriosus in preterm babies <32 weeks in NSW and ACT over the period 1992–2005: risk factors, associated morbidities and outcome. 12th Annual Congress of Perinatal Society of Australia and New Zealand, Queensland; abstract A41
27. Sehgal A, Coombs P, Tan K, McNamara PJ (2011) Spectral Doppler waveforms in systemic arteries and physiological significance of a patent ductus arteriosus. J Perinatol 31:150–156
28. Sehgal A, Kumarshingri PS (2013) Pulmonary hypertension in an infant treated with ibuprofen. Indian J Pediatr 80:697–699
29. Sehgal A, Paul E, Menahem S (2013) Functional echocardiography in staging for ductal disease severity: role in predicting outcomes. Eur J Pediatr 172:179–184
30. Sehgal A, Ramsden A, McNamara PJ (2012) Indomethacin impairs coronary perfusion in infants with hemodynamically significant ductus arteriosus. Neonatology 101:20–27
31. Teixeira LS, McNamara PJ (2006) Enhanced intensive care for the neonatal ductus arteriosus. Acta Paediatr 95:394–403
32. The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Investigators of the Vermont-Oxford Trials Network Database Project (1993) Pediatrics 91:540–5
33. van der Lugt NM, Lopriore E, Bökenkamp R, Smits-Wintjens VEHJ, Steggerda SJ, Walther FJ (2012) Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus. Eur J Pediatr 171:1673–1677
34. Van Overmeire B, Smets K, Lecoutere D, Van De Broek H, Weyler J, De Groote K, Langhendries JP (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. New Eng J Med 334:674–681
35. Van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P (2001) Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 138:205–211